Canada Contraceptive Market Size & Outlook, 2024-2030
Related Markets
Canada contraceptive market highlights
- The Canada contraceptive market generated a revenue of USD 948.5 million in 2024 and is expected to reach USD 1,267.8 million by 2030.
- The Canada market is expected to grow at a CAGR of 5% from 2025 to 2030.
- In terms of segment, contraceptive drugs was the largest revenue generating product in 2024.
- Contraceptive Devices is the most lucrative product segment registering the fastest growth during the forecast period.
Contraceptive market data book summary
| Market revenue in 2024 | USD 948.5 million |
| Market revenue in 2030 | USD 1,267.8 million |
| Growth rate | 5% (CAGR from 2025 to 2030) |
| Largest segment | Contraceptive drugs |
| Fastest growing segment | Contraceptive Devices |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Contraceptive Drugs, Contraceptive Devices |
| Key market players worldwide | Bayer AG, Cupid, Helm AG, Church & Dwight Co Inc, Organon & Co Ordinary Shares, Pfizer Inc, Viatris Inc, AbbVie Inc, Afaxys, Veru Inc, Agile Therapeutics Inc, Janssen Pharmaceuticals, China Resources Pharmaceutical Group Ltd Registered Shs Unitary 144A/Reg S, Crinetics Pharmaceuticals Inc |
Other key industry trends
- In terms of revenue, Canada accounted for 3.0% of the global contraceptive market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. contraceptive market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in North America and is projected to reach USD 751.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Contraceptive Market Scope
Contraceptive Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Crinetics Pharmaceuticals Inc | View profile | 210 | 6055 Lusk Boulevard, San Diego, CA, United States, 92121 | https://www.crinetics.com |
| China Resources Pharmaceutical Group Ltd Registered Shs Unitary 144A/Reg S | View profile | 72986 | 26 Harbour Road, 41st Floor, China Resources Building, Room 4104-05, Wanchai, Hong Kong | https://www.crpharm.com |
| Janssen Pharmaceuticals | View profile | 1-10 | Titusville, New Jersey, United States, North America | https://www.xarelto-us.com |
| Helm AG | View profile | 1001-5000 | Hamburg, Hamburg, Germany, Europe | https://www.helmag.com |
| Cupid | View profile | 51-100 | Nasik, Maharashtra, India, Asia | https://www.cupidlimited.com |
| Afaxys | View profile | 1-10 | Charleston, South Carolina, United States, North America | https://www.afaxys.com/ |
| Veru Inc | View profile | 233 | 2916 North Miami Avenue, Suite 1000, Miami, FL, United States, 33127 | https://www.verupharma.com |
| Agile Therapeutics Inc | View profile | 19 | 500 College Road East, Suite 310, Princeton, NJ, United States, 08540 | https://www.agiletherapeutics.com |
| Organon & Co Ordinary Shares | View profile | 10000 | 30 Hudson Street, Floor 33, Jersey City, NJ, United States, 07302 | https://www.organon.com |
| Viatris Inc | View profile | 38000 | 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 | https://www.viatris.com |
| Church & Dwight Co Inc | View profile | 5550 | 500 Charles Ewing Boulevard, Ewing, NJ, United States, 08628 | https://www.churchdwight.com |
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
Canada contraceptive market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to contraceptive market will help companies and investors design strategic landscapes.
Contraceptive drugs was the largest segment with a revenue share of 59.14% in 2024. Horizon Databook has segmented the Canada contraceptive market based on contraceptive drugs, contraceptive devices covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Canada contraceptive market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada contraceptive market databook
-
Our clientele includes a mix of contraceptive market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada contraceptive market , including forecasts for subscribers. This country databook contains high-level insights into Canada contraceptive market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada contraceptive market size, by intrauterine devices (iuds), 2018-2030 (US$M)
Canada Contraceptive Market Outlook Share, 2024 & 2030 (US$M)
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
